Evidence map›Paper›PMID 25487652›Full record

ArticleBMC biotechnology2014

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.

Juozas Nainys, Rita Lasickiene, Rasa Petraityte-Burneikiene, Jonas Dabrisius, Raimundas Lelesius, Vilimas Sereika, Aurelija Zvirbliene, Kestutis Sasnauskas, Alma Gedvilaite

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. BioprospectingFrontiers in bioengineering and biotechnology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Juozas NainysInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. juozas.nainys@gmail.com.
Rita LasickieneInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. rital@ibt.lt.
Rasa Petraityte-BurneikieneInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. rasa.burneikiene@bti.vu.lt.
Jonas DabrisiusInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. jdabrisius@gmail.com.
Raimundas LelesiusInstitute of Microbiology and Virology, Veterinary Faculty of Veterinary Academy, Lithuanian University of Health Sciences, Tilzes 18, LT-47181, Kaunas, Lithuania. lelesius@lva.lt.
Vilimas SereikaInstitute of Microbiology and Virology, Veterinary Faculty of Veterinary Academy, Lithuanian University of Health Sciences, Tilzes 18, LT-47181, Kaunas, Lithuania. sereika@lva.lt.
Aurelija ZvirblieneInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. aurelija.zvirbliene@bti.vu.lt.
Kestutis SasnauskasInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. kestutis.sasnauskas@bti.vu.lt.
Alma GedvilaiteInstitute of Biotechnology, Vilnius University, Graiciuno 8, LT-02241, Vilnius, Lithuania. agedv@ibt.lt.
Vilnius University · LTLithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPorcine circovirus type 2 (PCV2) is considered to be an important emerging pathogen associated with a number of different syndromes and diseases in pigs known as PCV2-associated diseases. It has been responsible for significant mortality among pigs and remains a serious economic problem to the swine industry worldwide leading to significant negative impacts on profitability of pork production.

resultsIn this study we have demonstrated that PCV2 capsid (Cap) protein based virus-like particles (VLPs) were efficiently produced in yeast S. cerevisiae and induced production of monoclonal antibodies (MAbs) reactive with virus-infected cells. Moreover, PCV2 Cap VLPs served as a highly specific recombinant antigen for the development of an indirect IgG PCV2 Cap VLP-based ELISA for the detection of virus-specific IgG antibodies in swine sera. Four hundred-nine serum samples collected from pigs in Lithuania were tested for PCV2-specific IgG to determine the sensitivity and specificity of the newly developed ELISA in parallel using a commercial SERELISA test as a gold standard. From 409 tested serum samples, 297 samples were positive by both assays. Thirty-nine sera from 112 serum samples were determined as negative by SERELISA but were found to be positive both in the newly developed indirect IgG PCV2 Cap VLP-based ELISA and the PCR test.

conclusionsWe have demonstrated that S. cerevisiae expression system is an alternative to insect/baculovirus expression system for production of homogenous in size and shape PCV2 Cap protein-based VLPs similar to native virions. Yeast expression system tolerated native virus genes encoding PCV2 Cap protein variants as well as the codon-optimized gene. Moreover, yeast-derived PCV2 Cap VLPs were capable to induce the generation of PCV2-specific MAbs that did not show any cross-reactivity with PCV1-infected cells. The high sensitivity and specificity of the indirect IgG PCV2 Cap VLP-based ELISA clearly suggested that this assay is potentially useful diagnostic tool for screening PCV2-suspected samples.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralCapsid ProteinsCircoviridae InfectionsCircovirusEnzyme-Linked Immunosorbent AssayMiceMice, Inbred BALB CSaccharomyces cerevisiaeSwineSwine DiseasesVirionAntibodies, MonoclonalAntibodies, ViralCapsid Proteins

Identifiers

PMID25487652
PMCPMC4265424
OpenAlexW2156500732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.